Cytological cervical screening is rather inefficient because of relatively high proportions of
false negative and false positive smears. To evaluate the efficiency of high‐risk human …

Objective To compare the detection rates of precancerous and cancerous cervical lesions by
human papillomavirus (HPV) DNA testing and by conventional cytology screening. Design …

Within the past 5 years, guidelines recognizing the value of HPV testing in both primary
cervical screening and in the management of abnormal cervical cytology have been …

High-risk human papillomaviruses (HR-HPV) are the necessary cause of cervical
carcinomas and there is an increasing interest in using HR-HPV DNA detection in …

The Canadian Cervical Cancer Screening Trial was a randomized controlled trial comparing
the performance of human papillomavirus (HPV) testing and Papanicolaou cytology to …

Background/Aims: Self sampling is considered an adjuvant tool to facilitate the participation
of women in cervical cancer screening programmes. This study aimed to evaluate whether …

Background Testing for human papillomavirus (HPV) DNA is more sensitive but less specific
than cytological analysis. Loss in specificity is most relevant in women younger than 35 …

Background Controversy remains over whether high-risk human papillomavirus (HPV) DNA
testing should be used as a primary screen for cervical cancer. The aims of our study were to …

This article has been corrected. The original version (PDF) is appended to this article as a
supplement. Background: Screening programs using conventional cytology have …

Since infection with oncogenic human papillomavirus (HPV) has been considered a
necessary cause of cervical cancer, tests for oncogenic HPV types have been proposed as …